The Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994
S.I. 1994/3144 · Made 8 December 1994
MEDICINES
Made 8th December 1994
Laid before Parliament 9th December 1994
Coming into force 1st January 1995
The Secretary of State, in exercise of the powers conferred by section 2(2) of the European Communities Act 1972f1, being designated for the purpose of that section in relation to medicinal productsf2, hereby makes the following Regulations:
Annotations to the whole text
Footnotes
- f1
- f2
-
See The European Communities (Designation) Order 1972 (S.I. 1972/1811).
Contents
- 1Citation, commencement and interpretation
- 2Responsibility for Member States' functions under the Regulations and Directives
- 3Marketing authorizations for relevant medicinal products
- 4Applications for the grant, renewal or variation of a United Kingdom marketing authorization
- 5Consideration, and grant or refusal, of an application for, or for renewal or variation of, a United Kingdom marketing authorization.
- 6Revocation, suspension or variation of a United Kingdom marketing authorization or the suspension of the use or marketing of medicinal products.
- 7Obligations of holders of marketing authorizations, and offences by holders of marketing authorizations and other persons
- 8Control of retail sale of supply of relevant medicinal products
- 9Consequential and other amendments of the Act and the Medicines Act 1971
- 10Application of enforcement provisions of the Act
- 11Other Schedules to have effect
- Signature
- Schedule 1: EXEMPTIONS AND EXCEPTIONS FROM THE PROVISIONS OF REGULATION 3
- 1Paragraph 1
- 2Paragraph 2
- 3Paragraph 3
- 4Paragraph 4
- 5Paragraph 5
- 6Paragraph 6
- 7Paragraph 7
- Schedule 2: PROCEDURAL PROVISIONS RELATING TO THE GRANT, REVOCATION AND SUSPENSION OF UNITED KINGDOM MARKETING AUTHORIZATIONS
- 1Interpretation
- 2Scope and application of the procedural provisions
- 3Scope and application of the procedural provisions
- 4Scope and application of the procedural provisions
- 5Requirement to consult the appropriate committee or the Medicines Commission
- 6Provisional opinion against authorization
- 7Licensing Authority’s decision
- 8Confirmation or alteration of the decision after taking into account the advice of the Medicines Commission
- 9Person appointed to hear representations
- 10Person appointed to hear representations
- 11Right to be heard by a person appointed or to make further representations
- 12Right to be heard by a person appointed or to make further representations
- 13Cases where suspension is to have immediate effect
- 14Cases where suspension is to have immediate effect
- Schedule 3: OFFENCES, PENALTIES ETC.
- 1Offences
- 2Offences
- 3Offences
- 4Offences
- 5Offences
- 6Offences
- 7Offences
- 8Offences
- 9Offences
- 10Offences
- 11Offences
- 12Offences
- 13Offences
- 14Penalties
- 15Miscellaneous
- 16Miscellaneous
- Schedule 4: MODIFICATIONS OF ENFORCEMENT PROVISIONS OF THE ACT
- 1Paragraph 1
- 2Paragraph 2
- 3Paragraph 3
- 4Paragraph 4
- 5Paragraph 5
- 6Paragraph 6
- 7Paragraph 7
- 8Paragraph 8
- 9Paragraph 9
- 10Paragraph 10
- 11Paragraph 11
- 12Paragraph 12
- 13Paragraph 13
- 14Paragraph 14
- Schedule 5: LABELS
- 1Interpretation
- 2Introductory
- 3Dispensed relevant medicinal products
- 4Delivery and storage
- 5Relevant medicinal products on a general sale list
- 6Relevant medicinal products not on a general sale list
- 7Prescription only relevant medicinal products
- 8Exemptions
- Schedule 6: TRANSITIONAL PROVISIONS
- 1Paragraph 1
- 2Paragraph 2
- 3Paragraph 3
- 4Paragraph 4
- 5Paragraph 5
- Schedule 7: CONSEQUENTIAL AMENDMENTS TO REGULATIONS
- 1Paragraph 1
- 2Paragraph 2
- 3Paragraph 3
- 4Paragraph 4
- 5Paragraph 5
- 6Paragraph 6
- 7Paragraph 7
- 8Paragraph 8
- 9Paragraph 9
- 10Paragraph 10
- 11Paragraph 11
- 12Paragraph 12
- 13Paragraph 13
- 14Paragraph 14
- 15Paragraph 15
- 16Paragraph 16
- 17Paragraph 17
- 18Paragraph 18
- 19Paragraph 19
- 20Paragraph 20
- 21Paragraph 21
- 22Paragraph 22
- Explanatory note